Emerald Health Pharmaceuticals has filed a Tier II Reg A+ preliminary prospectus seeking to raise $50 million by selling up to 10 million shares at $5 per share. The...

Blogger Marc Davis profiled Emerald Health (TSXV: EMH) (OTC: TBQBF) recently, discussing the strategy of its Executive Chairman, Dr. Avtar Dhillon, who is building a business focused on medical...